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Implication of the miR-184 and miR-204 Competitive RNA
Network in Control of Mouse Secondary Cataract
Andrea Hoffmann,1* Yusen Huang,1,2* Rinako Suetsugu-Maki,1 Carol S Ringelberg,3 Craig R Tomlinson,3
Katia Del Rio-Tsonis,4 and Panagiotis A Tsonis1
1

Department of Biology and Center for Tissue Regeneration and Engineering, University of Dayton, Dayton, Ohio, United States of
America; 2current affiliation: State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology,
Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao, China; 3Department of Medicine and Department of
Pharmacology and Toxicology, Dartmouth Hitchcock Medical Center, Dartmouth College, Lebanon, New Hampshire, United States
of America; 4Department of Zoology, Miami University, Oxford, Ohio, United States of America

The high recurrence rate of secondary cataract (SC) is caused by the intrinsic differentiation activity of residual lens epithelial cells
after extra-capsular lens removal. The objective of this study was to identify changes in the microRNA (miRNA) expression profile during mouse SC formation and to selectively manipulate miRNA expression for potential therapeutic intervention. To model SC, mouse
cataract surgery was performed and temporal changes in the miRNA expression pattern were determined by microarray analysis.
To study the potential SC counterregulative effect of miRNAs, a lens capsular bag in vitro model was used. Within the first 3 wks after
cataract surgery, microarray analysis demonstrated SC-associated expression pattern changes of 55 miRNAs. Of the identified
miRNAs, miR-184 and miR-204 were chosen for further investigations. Manipulation of miRNA expression by the miR-184 inhibitor (antimiR-184) and the precursor miRNA for miR-204 (pre-miR-204) attenuated SC-associated expansion and migration of lens epithelial
cells and signs of epithelial to mesenchymal transition such as α-smooth muscle actin expression. In addition, pre-miR-204 attenuated
SC-associated expression of the transcription factor Meis homeobox 2 (MEIS2). Examination of miRNA target binding sites for miR-184
and miR-204 revealed an extensive range of predicted target mRNA sequences that were also a target to a complex network of
other SC-associated miRNAs with possible opposing functions. The identification of the SC-specific miRNA expression pattern together with the observed in vitro attenuation of SC by anti-miR-184 and pre-miR-204 suggest that miR-184 and miR-204 play a significant role in the control of SC formation in mice that is most likely regulated by a complex competitive RNA network.
Online address: http://www.molmed.org
doi: 10.2119/molmed.2011.00463

INTRODUCTION
Cataracts are a major ophthalmologic
concern, with an incidence throughout
the population (1,2). Cataracts can result
from eye injury through trauma, exposure to sunlight and a variety of agerelated physiological manifestations including inflammatory diseases, diabetes
and genetic predisposition (3–6). Current
cataract therapies include surgical extra-

capsular lens fiber removal and synthetic
lens implantation that can lead to secondary cataract (SC), also known as posterior
capsular opacification in humans. In general, SC etiology includes the transdifferentiation of anterior capsule residual lens
epithelial cells into mesenchymal myofibroblast cells (epithelial-mesenchymal
transition [EMT]) that can migrate and
expand into the posterior area of the lens
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capsule. The corresponding lens opacity
results from EMT-associated changes in
crystallin proteins, upregulation of cytoskeletal proteins such as α smooth
muscle actin (α-SMA) and fibrotic extracellular matrix remodeling (7–9). In the
pursuit of novel prevention and postsurgical therapies, numerous studies have
focused on analyzing the etiology of SC
formation, looking at the genetic predisposition and epigenetics as well as genomic and proteomic gene expression
patterns (5,10,11). To study the detailed
mechanism of SC, rodent cataract surgery
models were successfully used, with lens
epithelial cells undergoing SC during the
initial days after lens fiber removal
(12–14). Recently, we suggested that
microRNA (miRNA)-dependent posttranscriptional regulation of lens
development–associated genes might
also play a role in lens regeneration (15).
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MicroRNAs are small proportional 22nucleotide-long noncoding RNAs that
regulate mRNA breakdown or translational interference of tissue-specific genes
expressed during development, proliferation, differentiation and cell death mechanisms (16,17). RNA interference therapy
was proposed as a therapeutic tool for a
variety of clinical conditions (18–20). A
recent study by Park et al. (21) proposed
that specific targeting of SC-associated
regulatory factors such as nuclear factorκB (NF-κB) by RNA interference might
provide a promising tool for postsurgical
prevention of SC-associated EMT. Correspondingly, this study uses a previously
established mouse cataract surgery model
for SC (12), microarray hybridization
technology (22) and lens capsular bag
culture to identify the miRNA expression
pattern after cataract surgery and to determine the regulatory role of selective
miRNAs, in particular miR-184 and miR204, on SC etiology.
MATERIALS AND METHODS
Mouse Cataract Surgery
Cataract surgery was performed according to Suetsugu-Maki et al. and
Medvedovic et al. (12,13,22) with modifications. C57BL/6 mice (8 wks old, female;
The Jackson Laboratory, Bar Harbor, ME,
USA) were anesthetized by intraperitoneal injections of ketamine and xylazine
(95 and 14.3 mg/kg, respectively). For
analgesia, buprenorphine (1 mg/kg) was
give subcutaneously. The cornea was incised, and anterior capsulectomy was
performed by removal of the lens core
and fiber cells from the lens capsular
bag. Capsular bags were washed with 1×
phosphate-buffered saline (PBS) containing Mg2+ and Ca2+ to remove residual
fiber cells. After 1, 2 and 3 wks of
cataract surgery, mice were euthanized
and eyeballs were removed to study SC
formation. The posterior eyeballs were
cut off and lens capsules were separated
from the inside of the eyeball. For the
control, intact lens capsules were collected from intact mouse eyes. The lens
capsules were incubated in RNAlater®

(Ambion, Austin, TX, USA) at 4°C
overnight, followed by storage of lens
capsules at –80°C.
Microarray Analysis
Lens tissue was homogenized in TRIzol
Reagent (Invitrogen, Carlsbad, CA, USA)
for total RNA isolation according to Trask
et al. (23). Total RNA purity, quantity and
quality were determined using a NanoDrop spectrophotometer ND-1000
(Thermo Scientific, Waltham, MA, USA)
and an Agilent Bioanalyzer 2100 (Agilent
Technologies, Santa Clara, CA, USA). The
miRNA was isolated from the total RNA
preparation using the Flash Page™ gel
system (Ambion). The purified miRNA
was amplified using the NCode™ miRNA
Amplification System (Invitrogen) from
which the sense strand RNA was isolated
using the PureLink™ Micro Kit (Invitrogen). The sense strand miRNA was labeled with cyanine-3 and used for hybridization on mouse miRNA microarray
8 × 15K slide version 2 containing probes
for 627 mouse and 39 mouse γ herpes
virus miRNAs from the Sanger database v
12.0 (Agilent Technologies). Agilent Feature Extraction software (24) depicted 55
miRNA probes that were detected on at
least one out of four arrays by determination of the signal-to-error ratio. Intensity
values for each individual time point were
adjusted by setting negative values to “1.”
Data are based on single values. Hierarchical clustering of mean centered intensities
was employed using a Euclidean distance
measure to generate a heat map for the 55
detectable probes using the open source
software Cluster/Treeview. The software
was written by Michael Eisen while at
Stanford University.
Capsular Bag Culture
A radial incision was made at the border of the cornea and the sclera using a
scalpel and scissors followed by lens extrusion using forceps. Lenses were
washed in Dulbecco’s modified Eagle
medium/F12 (DMEM/F12, 1× antibiotics/
antimycotics; Corning® cellgro®, Mediatech Inc., Manassas, VA, USA), and any
residual tissue on the outer lens capsule

was removed supported by incubation in
0.25% trypsin/EDTA (Cellgro) for 1–5
min. After submersion in DMEM/F12
supplemented with 10% fetal bovine
serum (FBS) (Sigma-Aldrich, St. Louis,
MO, USA), the posterior capsule was positioned on a ring support structure at the
base of the dish and the anterior capsule
was opened by making three clockwise
incisions, with incisions not extending the
lens equator by keeping the lens positioned using forceps. The capsule was
peeled from the lens fiber cell mass using
small scissors, and the posterior capsule
was pinned with the exterior facing the
bottom of a 3-mm culture dish and the
anterior edge forming a cuplike structure
(capsular bag) using six entomological
pins (D1; Watkins and Doncaster, Kent,
UK). Residual lens fibers were removed
by changing the medium to DMEM/F12
without FBS.
miRNA Target Prediction
Target binding sites for miR-184 and
miR-204 were analyzed according to
the current TargetScan (Bin3, Runx2,
Meis2 [listed below]) and PicTar (Meis2
[listed below]) prediction programs. Regarding Mus musculus (mmu) miRNAs,
TargetScan predicted conserved targets
for mmu-miR-184 (18 conserved targets)
and mmu-miR-204 (322 conserved targets) were screened to identify potential
SC-associated genes listed by the AmiGO
gene ontology database (http://amigo.
geneontology.org) under the GO terms
GO:0001837: epithelial to mesenchymal
transition (http://amigo.geneontology.
org/cgi-bin/amigo/term_details?term=
GO:0001837&session_id=4145amigo
1314025373) and GO:0002088: lens development in camera-type eye (http://
amigo.geneontology.org/cgi-bin/amigo/
term_details?term=GO:0002088&session_
id=4145amigo1314025373). The identified
genes were further analyzed for
microarray-identified SC-associated
miRNA binding sites using TargetScan
accessed August 2011.
TargetScan predicted targets for mmumiR-184 can be found at: http://www.
targetscan.org/cgi-bin/targetscan/

MOL MED 18:528-538, 2012 | HOFFMANN ET AL. | 529

MIR-184 AND MIR-204 IN SECONDARY CATARACT

vert_50/targetscan.cgi?mirg=mmu-miR184. TargetScan predicted targets for
mmu-miR-204 can be found at: http://
www.targetscan.org/cgi-bin/targetscan/
vert_50/targetscan.cgi?species=Mouse&
gid=&mir_c=&mir_sc=miR-204/
211&mir_nc=&mirg=&sortType=cs&incl_
nc=0. TargetScan 3′ untranslated regions
(UTR) for Bin3 can be found at: http://
www.targetscan.org/cgi-bin/targetscan/
vert_50/view_gene.cgi?taxid=10090&gs=
BIN3&showcnc=0&shownc=0. TargetScan
3′UTR for Runx2 can be found at: http://
www.targetscan.org/cgi-bin/targetscan/
vert_50/view_gene.cgi?taxid=10090&gs=
RUNX2&showcnc=0&shownc=0#miR204/211. TargetScan 3′UTR for Meis2 can
be found at: http://www.targetscan.org/
cgi-bin/targetscan/vert_50/view_gene.
cgi?taxid=10090&gs=MEIS2&showcnc=
0&shownc=0. To access PicTar 3′UTR for
Meis2, use: http://pictar.mdc-berlin.de/
cgi-bin/PicTar_vertebrate.cgi (search
terms: has-miR-204, gene ID NM_172315).
Transfection of Capsular Bags
Capsular bag cultures were transfected
using lipofectamine. Optimal transfection
efficiency for miRNA constructs was determined before experiments by using the
pMIR-REPORT luciferase system (Ambion). In brief, the pMIR-REPORT luciferase plasmid expressing luciferase
mRNA fused to the antisense sequence for
hsa-mir-148a cloned in the Spe1, and the
HindIII multiple cloning site was transfected alone (L-anti-miR) or cotransfected
with hsa-miR-148a (L-anti-miR plus miR148a). Firefly luciferase activity was reported from cell lysates 48 h after transfection according to the Promega Luciferase
Assay System by detecting counts per
minute (cpm) using a scintillation counter
as previously published (15) (Figure 2).
Cell lysates from nontransfected cells were
used to measure background cpm (control). Samples were done in triplicate, and
each sample included the average of
20 cpm measurements. Data were analyzed by unpaired Student t test, and P <
0.05 was used as a criterion for significance. Transfection efficiency of cy3labeled anti-miR control (AM17011; Am-

bion) at different concentrations (for example, 5, 50 and 500 nmol/L) with or without lipofectamine was determined after 24
and 48 h of transfection by counting the
number of cy3-labeled miRNAs localized
within cell bodies (Figure 2). Human miR184 inhibitor (anti-miR-184, AM10207),
anti-miR control (AM17011), precursor
miRNA for miR-204 (pre-miR-204,
PM11116) and pre-miR control (AM17120),
respectively, were mixed under optimized
transfection conditions at a concentration
of 50 μmol/L with 125 μL serum-free
DMEM/F12 for 15 min and combined
with the lipofectamine mixture under
short vortexing and incubation for another
15–30 min. Proportional three to four capsular bag explants per 3-mm Petri dish
were supplemented with serum-free
DMEM/F12 and transfected with the corresponding mixture.
Migration and Cell Expansion
Imaging was performed using a TS100
microscope (Nikon, Tokyo, Japan) under
a phase-contrast setting with a chargedcoupled device (CCD) camera (CoolSNAP
cf 2; Photometrics, Tucson, AZ, USA) and
imaging software (Metamorph; Molecular Devices, Eugene, OR, USA). Percent
cell confluence after capsular miRNA
transfection was quantified from two different donor eyes after 24 and 48 h. The
data were derived by dividing each capsular bag into four quadrants followed
by measuring the average area of cells
that migrated to the denuded area. Data
were analyzed by two-way analysis of
variance (ANOVA) by entering the standard deviation of two donor eyes with
four measurements each (representing
four quadrants). P < 0.05 was used as a
criterion for significance.
Immunohistochemistry
Imaging was performed using a TS100
microscope (Nikon, Tokyo, Japan) under
a fluorescence setting with a CCD camera
(CoolSnapcf2) and imaging software
(Metamorph). After the different transfection time periods, capsular bags were
washed twice with PBS, followed by fixation in 2% paraformaldehyde in PBS,
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0.1% Triton X-100 for 30 min and staining
with primary mouse monoclonal antibody α-SMA 1:250 (Sigma-Aldrich). Integrated optical density of α-SMA expression after capsular bag transfection with
miRNA constructs was quantified from
two donor eyes (anti-miRNA constructs)
and three donor eyes (pre-miRNA constructs) after 24, 48 and 72 h, respectively.
The data were derived by dividing each
capsular bag into four quadrants followed by measuring the integrated optical density of same-size panes in two different capsular locations (for example, the
capsular edge and migration border).
Data of anti-miRNA constructs were analyzed by two-way ANOVA by entering
the standard deviation of two donor eyes
with four measurements each (representing four quadrants). Data for pre-miRNA
constructs were analyzed by unpaired
Student t test and two-way ANOVA by
entering the standard error from three
donor eyes with four measurements each
(representing four quadrants). P < 0.05
was used as a criterion for significance.
Protein Extraction
After lens extrusion, capsular bag culture was established by opening the posterior part of the lens capsule and pinning
the anterior capsule with cells facing the
interior of the capsular bag to preserve
the maximum amount of lens epithelial
cells for miRNA transfection. A total of
four capsular bags were used per protein
sample. To preserve all the cells contained
in a sample, the growth medium containing supernatant was transferred to an Eppendorf tube. Capsular bag attached epithelial cells were detached by rigorous
flushing with 750 μL PBS, followed by
transfer of cells to the supernatantcontaining tube. Proteins were extracted
according to the NE-PER Nuclear and Cytoplasmic Extraction Kit (Pierce Biotechnology, Rockford, IL, USA). In brief, after
centrifugation at 2,000g and removal of
the supernatant, cells were taken up in
25 μL Cytoplasmic Extraction Reagent I
(CER I), vortexed and incubated on ice for
10 min. After addition of CER II, samples
were vortexed, incubated on ice for 1 min,
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for 10 min and centrifuged at 13,000g for
5 min. The supernatant containing the nuclear fraction was pooled with the cytosolic fraction to obtain total cellular protein
extracts.

Figure 1. MicroRNA expression profile after
cataract surgery. Dendrogram based on
clustered miRNA intensity values to demonstrate the subtle differences of miRNA
expression after different time points of
cataract surgery. The intensities are mean
centered, with red indicating values
higher than the average of all four groups
and green indicating lower values.

vortexed and centrifuged at 13,000g for 5
min. The cytoplasmic supernatant was
separated from the nuclear pellet. The nuclear pellet was dissolved in 15 μL Nuclear Extraction Reagent (NER), vortexed

Sodium Dodecyl Sulfate–
Polyacrylamide Gel Electrophoresis
(SDS-PAGE) and Western Blotting
The complete protein samples derived
from four lenses each were separated
on 10% sodium dodecyl sulfate–
polyacrylamide gels and transferred to
polyvinylidene fluoride (PVDF) membranes. PVDF membranes were incubated with the primary polyclonal antibodies for bridging integrator 3 (BIN3)
(ProteinTech Group, Chicago, IL, USA),
Meis homeobox 2 (MEIS2) (Abcam,
Cambridge, MA, USA), runt-related
transcription factor 2 (RUNX2), β-actin
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (loading control)
(Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Staining with primary antibodies was followed by fluoresceinlinked secondary antibody at 1:600
dilution and tertiary antibody antifluorescein AP conjugate 1:1,000 according to the enhanced chemifluorescence
Western Blotting Kit (Amersham, Piscataway, NY, USA), and membranes were
scanned with a Biospectrum 500 Imaging System with an LM26 and BioChemi
500 Camera f/1.2 and Vision Works LS
software. Antibody staining intensities
were measured using ImageGauge 4.1
(Fuji Photo Film). Three samples per
group with four lenses per sample were
analyzed. Intensities of primary antibody staining were normalized to the
β-actin or GAPDH loading controls
through division. For comparison of
controls versus miRNA treatments, a
two-tailed unpaired Student t test was
used. P < 0.05 was used as a criterion for
significance.
All animal studies were approved by
the University of Dayton Laboratory Animal Institutional Review Board.
All supplementary materials are available
online at www.molmed.org.

RESULTS
Cataract Surgery for miRNA
Expression Profiling
Previously, we demonstrated that SC
can be modeled in mice by surgical removal of lens fibers from the capsular
bag (12). The resulting lens regeneration
after extra-capsular lens fiber removal
consists of two critical phases. The initial
phase is during the first week of regeneration and is marked by upregulation of
EMT-specific extracellular matrix components, cytoskeletal proteins such as
α-SMA and downregulation of crystallins. The second phase begins at wks 2
and 3 and is marked by an upregulation
of lens structural proteins and lens differentiation (12,13). For the present study,
8-wk-old C57BL/6 mice underwent
cataract surgery by capsulectomy, as
previously described (12,13). Following 1,
2 and 3 wks after surgery, RNA was isolated from regenerating lenses to determine the miRNA expression profiles during these different time points.
Cataract Surgery Induces
SC-Dependent Expression of miRNAs
The broad-spectrum miRNA expression
profile was examined by hybridizing
miRNA probes to a microarray containing
probes for 627 mouse miRNAs from the
Sanger database v. 12.0. Microarray analysis revealed SC-associated changes in expression pattern of 55 regulatory miRNAs
after mouse cataract surgery (Figure 1).
A variety of lens development and
regeneration-specific miRNAs (miR-31,
miR-125b and a variety of the let-7/98
cluster, for example, let-7a, -7b, -7c, -7d, -7e
and -7f) were upregulated after 1 wk of
cataract surgery and declined to baseline
levels over the 3-wk regeneration period
(15,25–29). Regarding other lens-specific
miRNAs (25), miR-184 demonstrated an
upregulation after cataract surgery,
whereas the miR-204/211 cluster demonstrated a downregulation after cataract
surgery that continued declining over the
3-wk regeneration period. Further, several
miRNAs such as miR-23a and miR-15b,
that are known to play a role in regenerat-
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Figure 2. Determination of miRNA transfection efficiency. (A) Determination of 48-h transfection efficiency by confocal microscopy. (a, b, c) Nontransfected control. (d, e, f) Cells
transfected with cy3-labeled anti-miR control. (b, e) Cell bodies were labeled with TOTO3 (blue staining). (c, f) Phase-contrast overlay with red and blue panels for detection of
colocalization. The best transfection efficiency of proportional 85% was achieved at a
concentration of 500 nmol/L for 48 h, visible as red staining within TOTO-3–stained cell
bodies. (B) Determination of transfection efficiency by pMIR-REPORT™ luciferase system
(Ambion). Graph demonstrates measured luciferase activity in cpm after 48 h transfection in nontransfected (control) or MIR-REPORT™ luciferase plasmid expressing luciferase
mRNA fused to the antisense sequence for hsa-mir-148a (L-anti-miR), or cotransfection of
L-anti-miR with hsa-miR-148a (L-anti-miR plus miR-148a). Samples were done in triplicate,
and each sample included the average of 20 cpm measurements. Data were analyzed
by unpaired Student t test, and P < 0.05 was used as a criterion for significance. Error bars
represent standard errors. Firefly luciferase activity was successfully inhibited within the
cotransfected sample of L-anti-miR plus miR-148a (P < 0.05).

ing retinal pigment epithelium, demonstrated a SC-associated upregulation (30).
Similarly, SC-induced upregulation in
common mediators of eye and neural crest
development (for example, miR-23b and
miR-130a) were identified (31). We also
observed an upregulation of the proliferation inductive miR-22 after cataract surgery most likely corresponding to the SCassociated induction of lens epithelial (LE)
cell migration and expansion (32). Regarding the detection of EMT-specific miRNAs,
miR-21, miR-24 and miR-30d expression
was upregulated, whereas miR-30c was
downregulated in accordance with their
role in induction of fibrotic proliferation
and apoptosis (33–43).

Capsular Bag Culture Using
Anti-miR-184 and Pre-miR-204
The effect of miRNAs on SC etiology
was studied in a capsular bag culture
model that allows efficient manipulation
of selective miRNA expression with faster
outcomes compared with an animal surgery model and has been previously used
by our group and others (13,44). SC characteristics can be observed within the
first 3 d of capsular bag culture. When
looking at miRNAs that demonstrate
abundant expression in lens with a potential regulatory role in SC, miR-184 and
miR-204 represent promising candidates
(25). For instance, both of these miRNAs
exhibit differential expression patterns

532 | HOFFMANN ET AL. | MOL MED 18:528-538, 2012

during lens differentiation, regeneration
and cataract etiology (25,27,45,46). In addition, these two miRNAs were previously identified to possess binding sites
to the 3′UTRs of potential SC target
mRNAs; for example, miR-184 targets the
cataract-associated GTPase binding protein bridging integrator 3 [Bin3], and
miR-204 targets the homeobox transcription factor Meis2 and canonical Wnt signaling associated transcription factor
Runx2, respectively (29,47–49). In accordance with the SC observed opposing expression pattern of miR-204/211 versus
miR-184 and our previous observations
that demonstrated differential expression
of miR-184 and miR-204 during iris cell
dedifferentiation and lens regeneration in
the adult newt (27), both of these miRNAs
were selected for further investigation. To
inhibit potential miR-184–dependent effects on SC formation that might result
from the observed upregulation of miR184 after cataract surgery, the miRNA inhibitor anti-miR-184 and the corresponding anti-miR control were chosen.
Equivalent to the observed downregulation of miR-204/211 cluster after cataract
surgery and with regard to the close
sequence homology between miR-204
and miR-211, we simulated an overexpression of the miR204/211 cluster by
transfection of pre-miR-204 precursor
miRNA and the corresponding pre-miR
control. Before miRNA transfection of
capsular bag cultures, transfection efficiency was confirmed by microscopy and
luciferase assay (see Figure 2 for detailed
information).
Attenuation of SC-Associated Cell
Migration and Expansion by
Anti-miR-184
Within a 3-d time period, all capsular
bag cultures demonstrated SC characteristic migration and expansion of anterior
LE cell from the capsular edge into the
middle of the posterior capsular bag
area. Anti-miR control transfected cultures demonstrated a 22.73% ± 12.74%
confluence of capsular bags at d 1 and a
96.41% ± 5.06% confluence at d 2 (Figure 3), resulting in complete confluence
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at d 3 (data not shown). In contrast, antimiR-184 attenuated migration and expansion of LE cells significantly (P <
0.005, two-way ANOVA) to 6.49% ±
3.23% confluence of capsular bags at d 1
and 54.36% ± 0.05% confluence at d 2.

Figure 3. Attenuation of cell migration and expansion by anti-miR-184 and pre-miR-204. (A)
Cell migration and expansion of LE cells within capsular bag cultures monitored by phasecontrast microscopy after 0–2 d treatment with anti-miR-184 compared with anti-miR control and pre-miR-204 compared with pre-miR control. (B) Graphs demonstrate percent cell
confluence determined from d 1 and d 2 in (A) by measuring the average area of cells
that migrated to the denuded area of the capsular bag. The data were derived by dividing each capsular bag into four quadrants followed by measuring the average area of
cells that migrated to the denuded area. Data were analyzed by two-way ANOVA by entering the standard deviation from two donor eyes with four measurements each (representing four quadrants). Error bars represent standard deviations. P < 0.05 was used as a
criterion for significance.

Figure 4. Reduction of α-SMA expression after anti-miR-184 and pre-miR-204 treatment. (A)
α-SMA expression within capsular bag cultures detected by immunohistochemistry after
1–3 d treatment with anti-miR-184 compared with anti-miR control and pre-miR-204 compared with pre-miR control. (B) Example image demonstrating areas for determination of
IOD in Figure 5 at the capsular edge (yellow squares) and migration border (blue squares).

Attenuation of SC-Associated Cell
Migration and Expansion by
Pre-miR-204
Transfection with pre-miR control
demonstrated a SC characteristic appearance of LE cell migration and expansion
to the middle of capsular bags with
23.07% ± 0.34% cell confluence at
d 1 and 94.66% ± 2.74% confluence at d 2
(see Figure 3), resulting in complete confluence at d 3 (data not shown). Transfection with pre-miR-204 was comparable to
observations with anti-miR-184, including a significant attenuation of LE cell
migration and expansion (P < 0.0001,
two-way ANOVA) to 5.66% ± 1.32% confluence of capsular bags at d 1 and
49.74% ± 0.72% confluence at d 2.
Attenuation of SC-Associated α-SMA
Expression by Anti-miR-184
After 3 d, transfection of capsular bags
with anti-miR-184, or anti-miR control
expression of α-SMA, was analyzed by
immunohistochemistry (Figure 4). In
general, α-SMA expression was mainly
localized at capsular edges and migration borders and demonstrated an increasing α-SMA integrated optical density (IOD) over the 3-d time period in the
presence of both anti-miR-184 and antimiR control (compare Figure 4 and Figure 5A). In comparison to the control,
anti-miR-184 demonstrated an attenuation of α-SMA expression at the capsular
edge over the 3-d time period with an
IOD of 5.79 ± 0.01 at d 1 (versus 9.71 ±
2.93, anti-miR control) and 18.55 ± 4.79 at
d 3 (versus 25.16 ± 1.96, anti-miR control)
(P < 0.05, two-way ANOVA) (Figure 5A).
In addition, an attenuation of α-SMA expression could be observed at the migration border in the presence of anti-miR184 with an IOD of 1.67 ± 0.29 at d 1
(versus 1.99 ± 0.18, anti-miR control) and
6.54 ± 1.04 at d 3 (versus 9.56 ± 0.36, anti-
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miR control) (P < 0.005, two-way
ANOVA).
Attenuation of SC-Associated α-SMA
Expression by Pre-miR-204
Similarly, 3-d transfection of capsular
bags with either pre-miR-204 or pre-miR
control demonstrated an increasing
α-SMA expression at the capsular edges
and migration borders (compare Figure 4
and Figure 5B). In comparison to the control, pre-miR-204 demonstrated an attenuation of α-SMA expression over the 3-d
time period at the capsular edge with an
IOD of 3.52 ± 0.44 at d 1 (versus 5.8 ± 1.24,
pre-miR control) and 10.2 ± 0.66 at d 3
(versus 9.3 ± 0.38, pre-miR control) (P <
0.05, two-way ANOVA) (Figure 5B). Because capsular bags transfected with premiR-204 had reached complete confluence
at d 3, the two-way ANOVA did not yield
any conclusive results regarding temporal
changes of α-SMA IOD over the 3-d time
period. Thus, a significant attenuation of
α-SMA expression could be observed at
the migration border after 2 d transfection
with pre-miR-204 with an IOD of 1.23 ±
0.07 versus 2.65 ± 0.5 (pre-miR control)
(P < 0.05, Student t test).
Regulation of SC-Associated Target
Expression by Anti-miR-184
One of the predicted miR-184 targets
includes the mRNA for GTPase Bin3. The
selective knockout of Bin3 was found to
promote cataract formation in Bin3
knockout mice (29,50). Correspondingly,
we hypothesized that the presence of
anti-miR-184 might limit a potential miR184–dependent downregulation of BIN3
expression during SC. Unexpectedly,
Western blotting analysis demonstrated
no changes in BIN3 protein expression
after 1, 3 and 18 h capsular bag transfection with anti-miR-184 (data not shown).
Regulation of SC-Associated Target
Expression by Pre-miR-204
One of the predicted mRNA targets
regulated by miR-204 includes the transcription factor MEIS2 (49,51–53). Previously, miR-204 downregulation and, correspondingly, MEIS2 upregulation was

Figure 5. Reduction of α-SMA expression after anti-miR-184 and pre-miR-204 treatment.
Graph representing data analysis of α-SMA IOD derived from immunohistochemistry in
Figure 4. α-SMA expression within capsular bag cultures detected by immunohistochemistry after 1–3 d treatment with anti-miR-184 compared with anti-miR control (A) and premiR-204 compared with pre-miR control (B). Data of anti-miRNA constructs were analyzed
by two-way ANOVA by entering the standard deviation from two donor eyes with four
measurements each (representing four quadrants). Error bars represent standard deviations. Data for pre-miRNA constructs were analyzed by unpaired Student t test and twoway ANOVA, by entering the standard error from three donor eyes with four measurements each (representing four quadrants). Error bars represent standard errors. P < 0.05
was used as a criterion for significance.

suggested to cause abnormal lens development in the Medaka fish (47). Accordingly, when testing upregulation of miR204 by pre-miR-204, we expected a
downregulation of MEIS2 expression.
Western blotting demonstrated a 15%
downregulation of MEIS2 after 3-h transfection of capsular bags with pre-miR204 (P < 0.05) (Figure 6A). Interestingly,
MEIS2 protein expression demonstrated
a proportional 7% downregulation after
a 3-h transfection of capsular bags with
anti-miR-184 (P = 0.055), suggesting existence of a counterregulatory pathway between the two miRNAs miR-204 and
miR-184 (Figure 6B). No changes of
MEIS2 protein expression could be found
at the earlier 1-h or later 18-h time point
(data not shown).
Besides Meis2, miR-204 was predicted
to regulate other EMT-associated target
mRNAs such as Smad4 and cell cycle regulators Cdc7, Cdc25b, E2f3 and Runx2
(48,54,55). According to our previous
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study that demonstrated an attenuation
of SC-associated Runx2 mRNA expression in the presence of complement receptor C5 antagonist after 1 wk of
cataract surgery, Runx2 was chosen as an
additional target for pre-miR-204 treatment (13). In contrast to an expected attenuation of RUNX2, no changes in
RUNX2 protein levels could be detected
in the presence of miR-204 at the different time points of 1, 3 and 18 h of capsular bag culture (data not shown).
Bioinformatic Analysis of MiR-184 and
MiR-204 Target 3′UTR Reveals Multiple
Binding Sites of Other Competitive
miRNAs
To explain these results, we performed
a detailed bioinformatic analysis of all potential SC-associated mRNAs that are targeted by miR-184 or miR-204. We find
that several of these target mRNAs contain 3′UTR binding sites for miRNAs,
with opposing expression patterns during
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cataract-associated target mRNAs, for example, the GTPase binding protein Bin3,
the homeobox transcription factor Meis2
and canonical Wnt signaling associated
transcription factor Runx2, respectively
(29,47,48). Correspondingly, miRNA-associated counterregulation of these EMTassociated target mRNAs might prevent
formation of SC.

Figure 6. Attenuation of MEIS2 expression after pre-miR-204 and anti-miR-184 treatment.
Western blot analysis of MEIS2 expression within LE cells after 3 h of pre-miR control or premiR-204 treatment (A) or anti-miR control or anti-miR-184 treatment (B). Blots were stained
with the primary polyclonal antibodies for MEIS2 as well as β-actin or GAPDH (loading
control). Graphs represent Image Gage 4.1 densitometric analysis of MEIS2 expression
ratio in the upper panel. Three samples per group with four lenses per sample were analyzed. Intensities of MEIS2 were normalized to the β-actin or GAPDH loading controls
through division. For comparison of controls versus miRNA treatments, a two-tailed unpaired Student t test was used. Error bars represent standard errors. P < 0.05 was used as a
criterion for significance.

SC, which alludes to the existence of a
complex network (Figure 7). For example,
Bin3 mRNA demonstrates 3′UTR binding
sites for miR-184 but also for miRNAs of
the Let-7/98 cluster, which are also upregulated during SC (Figure 7A). Thus, the
Let7 miRNA members might render a potential anti-miR-184 targeting of Bin3 ineffective. Likewise, mRNAs for Meis2 and
Runx2 contain many other competitive
miRNAs binding sites in their 3′UTR besides miR-204, suggesting that a potential
downregulation by miR-204 might be rendered ineffective as well (Figure 7B) (see
Discussion for more details on the possible regulation).
In summary, the results conclude that
miR-184 and miR-204 play a significant
role in the control of SC etiology in mice
and are most likely regulated through a
complex networking with other miRNAs.
DISCUSSION
Role of miRNAs in Attenuation of SC
Posttranscriptional RNA interference
through miRNA or small interfering
RNA (siRNA) represents a new thera-

peutic tool for treatment of cancer, cardiovascular disease, fibrosis and antiviral
therapy (56–59). Recently, the group of
Park et al. further confirmed the suitability of RNA interference therapy for treatment of SC (21). Accordingly, this study
focused on identifying the SC-associated
miRNA expression pattern after cataract
surgery using microarray technology.
The identified miRNA expression pattern
included 55 miRNAs with different ontologies, for example, regulation of cell
growth, differentiation and development,
EMT-dependent fibrosis and lens development and cataract. Interestingly, when
looking at changes in lens-specific
miRNAs, miR-184 demonstrated a SCassociated upregulation in comparison to
an observed downregulation of the miR204/211 cluster (25). These miRNAs have
also been identified to play a role during
iris cell dedifferentiation and lens regeneration in the adult newt, supporting a
potential lens-regenerative function (27).
Having in mind the potential therapeutic
role of miRNAs in prevention of SC,
these two selected miRNAs have predicted binding sites to the 3′UTR of

Evidence of SC Attenuation by
Anti-miR-184 and Pre-miR-204
We found clear evidence that both
anti-miR-184 and pre-miR-204 can attenuate SC within the capsular bag model,
supporting the SC regulatory role of
these two miRNAs. Both of these miRNAs were able to attenuate anterior LE
cell migration and expansion from the
capsular edge into the middle of the posterior capsular bag area with a proportional 3.5-/4-fold decrease of cell confluence at d 1 and 1.8-/1.9-fold decrease at
d 2. This result is further supported by
attenuation of α-SMA expression with a
proportional 1.4-fold downregulation of
α-SMA IOD at the capsular edge and a
proportional twofold downregulation of
α-SMA IOD at the migration border over
the 3-d time period in the presence of
anti-miR-184 or pre-miR-204.
Bioinformatic Analysis of miR-184
Target 3′UTR Reveals Multiple Binding
Sites of Other Competitive miRNAs
One explanation for the insufficient
regulation of BIN3 expression by antimiR-184 targeting is the existence of
other competitive miRNA binding sites
within the 3′UTR of Bin3 mRNA. For instance, TargetScan (http://targetscan.org)
predictions identify a binding site for
miR-184 at the position 264–270 of the
Bin3 3′UTR, thus also predicting a binding site for the let-7/98 cluster at position 348–354 (compare the Bin3 Web address in the Materials and Methods
section and Figure 7A). Because of the
observed upregulation of most let-7/98
cluster members, the intended miR-184
attenuation by anti-miR-184 might not be
sufficient in preventing a potential SCassociated downregulation of BIN3.
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Figure 7. MicroRNA 184 and 204 competitive RNA network during SC-associated
EMT. Schematic diagram demonstrating
binding patterns of SC-associated miRNAs
to the 3′UTR of potential SC expressed target mRNAs. Target mRNAs are shown for
mmu-miR-184 (A) and mmu-miR-204 (B)
identified by TargetScan predictions followed by screening for potential SCassociated genes that play a role during
EMT listed by the AmiGO gene ontology
under the GO terms GO:0001837:epithelial
to mesenchymal transition and GO:0002088:
lens development in camera-type eye.
MicroRNA 3′UTR binding sites are demonstrated in circles with numbers depicting
the specific type of microRNA. SCassociated microRNA upregulation is indicated by red circles and downregulation
by green circles. SC-associated target
mRNA upregulation is in red and downregulation is in green.

Including Bin3 TargetScan predicted a
total of 18 mmu-miR-184–specific target
mRNAs, suggesting that the observed SC
attenuation might also include miR-184–
dependent regulation and targeting of
other mRNAs (compare to the mmumiR-184 Web address in Materials and
Methods).
Bioinformatic Analysis of miR-204
Target 3′UTR Reveals Multiple Binding
Sites of Other Competitive miRNAs
Besides binding of miR-204/211 at position 3770–3776 within the 3′UTR of

Runx2, TargetScan predictions identify
multiple other miRNA binding sites, including the mir23a/b cluster at position
996–1002 and two miR-30c/d clusters at
position 3445–3451 and position 3456–
3462 (compare the Runx2 Web addresses
in Materials and Methods and Figure 7B).
In accordance with the SC-associated upregulation of miR-30d and the miR-23a/b
cluster, the pre-miR-204–dependent effect
on Runx2 target mRNA expression might
be rendered ineffective.
Similarly, the PicTar Web interface
(http://pictar.mdc-berlin.de) predicts
multiple other miRNA binding sites for
the Meis2 3′UTR besides miR-204/211,
including SC upregulated miR-23a/b,
miR-27a and the let-7/98 cluster, as well
as miR-181b. In contrast to older
TargetScan predictions, the current parameters of TargetScan do not include
any defined target binding site for the
miR-204/211 cluster within the Meis2
3′UTR. Thus, current TargetScan predictions for Meis2 match the PicTar predictions regarding binding sites for miR23a/b, miR-27a and the let-7/98 cluster,
but also include miR-22, miR-30d and SC
downregulated miR-30c (compare the
Meis2 Web addresses in Materials and
Methods and Figure 7B). Correspondingly, the potential competition of these
other Meis2-specific miRNAs with miR204–dependent regulation of MEIS2 expression, might account for the limited
15% downregulation of MEIS2 by premiR-204 in our experiment.
Including Meis2 and Runx2 TargetScan
predicted a total of 322 mmu-miR-204–
specific target mRNAs, suggesting that
miR-204 regulation of other mRNAs
might also be relevant for the observed
SC attenuation (compare to the mmumiR-204 Web address in Materials and
Methods).
Bioinformatic Analysis of miR-184 and
miR-204 Target Gene Ontology
Database Reveals a Complex miRNA
Network
To support the suggestion that miR-184
might regulate other SC-associated
target mRNAs besides Bin3, the 18

536 | HOFFMANN ET AL. | MOL MED 18:528-538, 2012

Figure 8. Summary diagram of miR-184
and miR-204 competitive RNA network in
control of mouse secondary cataract. The
SC-determined broad-spectrum miRNA
expression profile revealed changes in expression patterns of major lens differentiation/regeneration- and EMT-associated
miRNAs (upregulation indicated with red
arrows and downregulation indicated
with green arrows). Accordingly, the
microRNAs miR-184 and miR-204 were
chosen for further analysis because of
their differential expression patterns during
SC that can also be observed during lens
differentiation, regeneration and cataract
etiology (25,27,34,35). The experimental
manipulation of miRNA expression by the
anti-miR-184–dependent downregulation
of miR-184 and pre-miR-204–dependent
upregulation of miR-204 is suggested to result in the mechanistic interplay with other
co- or counterregulatory miRNAs for the
modulation of potential SC target mRNAs
and attenuation of SC EMT. Vice versa, the
miRNA-dependent modulation of SC target mRNAs might include alterations in
transcription factors relevant for expression
of SC EMT attenuating miRNAs.

TargetScan–predicted miR-184 targets
were screened for a potential match with
genes listed by the AmiGO gene ontology
database (http://amigo.geneontology.org)
under the GO terms GO:0001837:epithelial
to mesenchymal transition and
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GO:0002088:lens development in cameratype eye. Besides Bin3, two other potential
miR-184 target mRNAs, for example, eye
development–associated factors Epb41l5
and Zic4, were identified by this method
(60,61) (Figure 7A and Supplementary Figure 1A). Interestingly, transforming
growth factor (TGF)-β–dependent upregulation of EPB41L5 participates in posttranscriptional regulation of cadherin and integrin important for EMT during mouse
gastrulation. Thus, the role of EPB41L5 in
SC-associated EMT in adult mice remains
to be determined (62).
Similarly, the 322 TargetScan predicted
miR-204 targets were screened for a potential match with genes listed by the
AmiGO gene ontology database (http://
amigo.geneontology.org) under the GO
terms GO:0001837 and GO:0002088. Besides Meis2 and Runx2, nine potential SCassociated miR-204 target mRNAs were
identified. For instance, the miR-204 targets Meis1, Wnt4, Foxc1, Hnrnpa2b1,
Tfap2a, Mafg and Sox1 represent important
factors in regulation of eye development
(63–69) (Figure 7B and Supplementary
Figure 1B). In addition, the two identified
miR-204 targets Dlg1 and Tgfbr2 represent
some potential candidates for regulation
of SC-dependent EMT (70–72). For instance, upregulation of TGF-β2 receptors
(TGFBR2) can be found in regenerating
lens epithelial cells after UVB irradiation
(72). In addition, DLG1 downregulation
was associated with EMT in a mouse ocular tumor model (70).
Interestingly, when looking at expression of SC-associated miRNAs in correlation with binding to miR-204 target
mRNAs, mRNAs of the major developmental factors, for example, Wnt4, Foxc1
and Hnrnpa2b, are solely regulated by
miR-204/211 with two binding sites of
miR-204/211 within the 3′UTR of Wnt4
(Supplementary Figure 1B). In contrast,
3′UTRs of Tfap2a and Sox11 seem to be
coregulated by miR-204/211 and miR92a. In addition, 3′UTRs of Meis2, Runx2,
Tgfbr2, Dlg1, Meis1 and Sox11 share binding sites for the miR-23a/b cluster, suggesting a miR-204 counterregulatory
function of miR-23a/b. Further common

miRNA binding sites include the let-7/98
cluster in the 3′UTR of Bin3 and Meis2
and the miR-30c/d cluster in the 3′UTR
of Epb41l5 and Zic4 as well as Meis2,
Runx2 and Mafg. These findings further
support existence of a competitive
miRNA network for target mRNAs
regulated by miR-184 and miR-204.
CONCLUSION
In summary, our study demonstrates
the complex miRNA network interactions
during formation of SC in mice. Although
the tested miRNAs, for example, antimiR-184 and pre-miR-204, achieved a partial attenuation of SC-associated EMT,
most likely, the mechanistic interplay of
these miRNAs with potential SC target
mRNAs and other co- or counterregulatory miRNAs needs to be considered (see
Figure 8 for further explanation). Such
miRNA networks have previously been
suggested by our group and others, including a recent hypothesis that underlines the existence of a competitive endogenous RNA (ceRNA) network
(15,73–75). With this in mind, our study
opens new avenues for future studies that
target the competitive miRNA network
for SC therapy and other diseases.
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